
Tiltbio
TILT Biotherapeutics is a clinical-stage biotechnology company creating the next generation of immunotherapies for solid tumors.
$25M Series B+ ·
Source: fundraisingfox.com
Funding history ↓Signals
Website registeredMay 30, 2013 (13 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $25M | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- AHAkseli Hemminki Founder & CEOsource: tiltbio.com
Companies like Tiltbio
AAkamis Bio$60M Series A · Dec 2024
IInnornaSeries B+ · Apr 202233T Biosciences$40M Series A · Aug 2022
DDeck BioSeed · Apr 2026
TTorl Bio$96M Series B+ · Oct 2025
WWaypoint Bio$20M Series A · Jun 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tiltbio (get a free API key).